Quick Answer
Dolby Laboratories, Inc. reported Diluted EPS of $2.62 per share for fiscal year 2025.
Dolby Laboratories, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $2.62 | -2.6% |
| 2024 | $2.69 | +31.2% |
| 2023 | $2.05 | +13.3% |
| 2022 | $1.81 | -39.1% |
| 2021 | $2.97 | +32.0% |
| 2020 | $2.25 | -7.8% |
| 2019 | $2.44 | +525.6% |
| 2018 | $0.39 | -80.5% |
| 2017 | $2.00 | +10.5% |
| 2016 | $1.81 | +3.4% |
| 2015 | $1.75 | -12.1% |
| 2014 | $1.99 | +8.2% |
| 2013 | $1.84 | -25.2% |
| 2012 | $2.46 | -10.5% |
| 2011 | $2.75 | +11.8% |
| 2010 | $2.46 | +16.6% |
| 2009 | $2.11 | +21.3% |
| 2008 | $1.74 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.55 | -21.4% | +14.6% |
| June 30, 2025 | $0.48 | +20.0% | -48.9% |
| March 31, 2025 | $0.94 | -6.9% | +34.3% |
| December 31, 2024 | $0.70 | +1.4% | +75.0% |
| June 30, 2024 | $0.40 | +135.3% | -60.4% |
| March 31, 2024 | $1.01 | +3.1% | +46.4% |
| December 31, 2023 | $0.69 | -15.9% | +305.9% |
| June 30, 2023 | $0.17 | -56.4% | -82.7% |
- Dolby Laboratories, Inc. showed a decrease of -2.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, Dolby Laboratories, Inc.’s diluted eps has grown by 50.6% (from $1.74 per share to $2.62 per share).
- The most recent figure is from Dolby Laboratories, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: